# Drug Enforcement Administration

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/drug-enforcement-administration-company
Canonical HTML page: https://getyourbrief.com/entity/drug-enforcement-administration-company

## Timeline

- **2026-08-17**: Post-Hearing Briefs Due — Parties submit final briefs to Administrative Law Judge Derek C. Julius, summarizing their arguments on the evidentiary record and legal standards. The recommendation on rescheduling is expected to follow shortly thereafter.
- **2026-08-16**: MMJ International Holdings issues legal warning — MMJ said that operational implementation of the administration's cannabis agenda does not equal legal finality and that its federal challenges could yield a stay, remand, vacatur, or targeted relief.
- **2026-08-15**: CNBC reports cannabis as emerging midterm issue — A CNBC report highlighted marijuana policy as an emerging 2026 midterm issue, noting ballot measures in Massachusetts and Idaho and gubernatorial races in Kansas and Iowa.
- **2026-07-16**: Senate Democrats reintroduce Cannabis Administration and Opportunity Act — 17 Senate Democrats reintroduced the CAOA, maintaining federal cannabis reform pressure while administrative actions proceed.

## Recent coverage (5 stories, network-wide)

### MMJ: AG Order 6754-2026 Faces Stay, Remand or Vacatur
2026-08-16 18:58:47 · Sector: legal · Sentiment: Negative · Impact: 6/10 · Sources: 2

For legal and regulatory professionals, MMJ's statement exposes the volatile gap between administrative implementation and judicial finality. The dispute could generate stay, remand, or vacatur rulings that determine whether operators can rely on current federal cannabis policies.
Full story: https://getlegalbrief.com/story/mmj-federal-challenges-ag-order-6754-2026-legal-risk

### IRS 280E Relief and CMS Hemp Move Face Legal Uncertainty
2026-08-16 18:58:37 · Sector: health · Sentiment: Negative · Impact: 6/10 · Sources: 2

Health systems and health IT vendors building around CMS's hemp-derived cannabinoid initiative are on contested regulatory ground. A successful federal challenge could stay or remand the program, changing compliance and reimbursement calculations.
Full story: https://gethealthbrief.com/story/cms-hemp-280e-legal-uncertainty-health-systems

### Cannabis 280E Tax Relief Faces Clawback Risk Amid Litigation
2026-08-16 18:58:26 · Sector: finance · Sentiment: Negative · Impact: 6/10 · Sources: 2

Investors and lenders in cannabis and hemp face event risk from MMJ's federal challenges to the administration's accelerated policies. Current 280E tax relief and DEA registration activity may be reversed if courts intervene.
Full story: https://getfinancebrief.com/story/cannabis-280e-tax-relief-clawback-litigation

### AG Order 6754-2026 Could Still Face Vacatur, MMJ Warns
2026-08-16 18:58:15 · Sector: bio · Sentiment: Negative · Impact: 6/10 · Sources: 2

Biotech and pharma teams evaluating cannabinoid-derived drugs face unsettled federal scheduling and reimbursement policy. MMJ's litigation could alter DEA and CMS pathways through stay, remand, or vacatur.
Full story: https://getbiobrief.com/story/dea-cannabis-rescheduling-6754-2026-biotech-risk

### DEA's 5-Part Medical-Use Test Under Fire as Marijuana Rescheduling Hearing Heads to August 17 Briefs
2026-08-10 03:18:11 · Sector: legal · Sentiment: Neutral · Impact: 6/10 · Sources: 2

ALJ Julius's upcoming recommendation in the DEA marijuana rescheduling hearing may challenge the government's novel approach of limiting Schedule III status to state-licensed medical programs, after DEA scientist testimony cast doubt on whether such programs satisfy the Controlled Substances Act's rigorous medical-use standard.
Full story: https://getlegalbrief.com/story/dea-marijuana-rescheduling-legal-tensions

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.